Cardiologists reveal the unexpected symptoms of clogged arteries and underlying heart disease that you should know about. The ...

A research team revealed that insulin-like growth factor-binding protein 6 (IGFBP6) serves as a potential therapeutic target ...

NEW equations, named AROSE, have been developed to better predict the 10-year risk of atherosclerotic cardiovascular disease ...

The following is a summary of “Lipid Management in US Commercial and Medicare Enrollees with Atherosclerotic Cardiovascular ...

A research team led by Prof. WENG Jianping from the University of Science and Technology of China (USTC) of the Chinese ...

Among older adults and adults with low ASCVD risk for whom aspirin is not recommended, use of aspirin decreased after 2019 ...

Cutaneous lupus erythematosus (CLE) is associated with an increased risk for atherosclerotic cardiovascular disease (ASCVD).

Individuals with cutaneous lupus erythematosus have an increased ASCVD risk when compared with those without cutaneous lupus erythematosus.

Many historically underrepresented groups, individuals on Medicaid and some without insurance at low atherosclerotic risk continue to take low-dose aspirin despite bleeding risk, in contrast to recent ...

After guideline changes, aspirin use dropped off overall, even for higher-risk patients in whom it might still be considered.

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality globally, posing a particularly significant ...